Abstract
In recent years, a new class of designer drugs has appeared on the drugs of abuse market in many countries, namely, the so-called beta-keto (bk) designer drugs such as mephedrone (bk-4-methylmethamphetamine), butylone (bk-MBDB), and methylone (bk-MDMA). The aim of the present study was to identify the metabolites of mephedrone in rat and human urine using GC-MS techniques and to include mephedrone, butylone, and methylone within the authors’ systematic toxicological analysis (STA) procedure. Six phase I metabolites of mephedrone were detected in rat urine and seven in human urine suggesting the following metabolic steps: N-demethylation to the primary amine, reduction of the keto moiety to the respective alcohol, and oxidation of the tolyl moiety to the corresponding alcohols and carboxylic acid. The STA procedure allowed the detection of mephedrone, butylone, methylone, and their metabolites in urine of rats treated with doses corresponding to those reported for abuse of amphetamines. Besides macro-based data evaluation, an automated evaluation using the automated mass spectral deconvolution and identification system was performed. Mephedrone and butylone could be detected also in human urine samples submitted for drug testing. Assuming similar kinetics in humans, the described STA procedure should be suitable for proof of an intake of the bk-designer drugs in human urine.
Similar content being viewed by others
References
Bossong MG, Van Dijk JP, Niesink RJ (2005) Addict Biol 10:321–323
Kamata HT, Shima N, Zaitsu K, Kamata T, Miki A, Nishikawa M, Katagi M, Tsuchihashi H (2006) Xenobiotica 36:709–723
Shimizu E, Watanabe H, Kojima T, Hagiwara H, Fujisaki M, Miyatake R, Hashimoto K, Iyo M (2007) Prog Neuropsychopharmacol Biol Psychiatry 31:288–291
Nagai F, Nonaka R, Satoh Hisashi KK (2007) Eur J Pharmacol 559:132–137
Maurer HH, Pfleger K, Weber AA (2007) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
Zaitsu K, Katagi M, Kamata HT, Kamata T, Shima N, Miki A, Tsuchihashi H, Mori Y (2009) Forensic Sci Int 188:131–139
Sauer C, Peters FT, Haas C, Meyer MR, Fritschi G, Maurer HH (2009) J Mass Spectrom 44:952–964
McKay AF, Ott WL, Taylor GW, Buchanan MN, Crooker JF (1950) Can J For Res 28:683–688
Ewald AH, Ehlers D, Maurer HH (2008) Anal Bioanal Chem 390:1837–1842
Maurer HH, Pfleger K, Weber AA (2011) Mass spectral library of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
Maurer HH, Pfleger K, Weber AA (2007) Mass spectral library of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
Meyer MR, Peters FT, Maurer HH (2010) Clin Chem. doi:10.1373/clinchem.2009.135517
Michaelis W, Russel JH, Schindler O (1970) J Med Chem 13:497–503
Shin H, Park J (1994) Korean Biochem J 27:357–361
Springer D, Fritschi G, Maurer HH (2003) J Chromatogr B Analyt Technol Biomed Life Sci 796:253–266
Peters FT, Meyer MR, Fritschi G, Maurer HH (2005) J Chromatogr B Analyt Technol Biomed Life Sci 824:81–91
McLafferty FW, Turecek F (1993) Interpretation of mass spectra. University Science Books, Mill Valley
Smith RM, Busch KL (1999) Understanding mass spectra—a basic approach. Wiley, New York
Maurer HH, Pfleger K, Weber AA (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
Kovats E (1958) Helv Chim Acta 41:1915–1932
de-Zeeuw RA, Franke JP, Maurer HH, Pfleger K (1992) Gas chromatographic retention indices of toxicologically relevant substances and their metabolites (Report of the DFG Commission for Clinical Toxicological Analysis, Special Issue of the TIAFT Bulletin). Wiley-VCH, Weinheim
DFG Senatskommission für Klinisch-toxikologische Analytik (1982) J Clin Chem Clin Biochem 20:699
Schifano F, Corkery J, Deluca P, Oyefeso A, Ghodse AH (2006) J Psychopharmacol 20:456–463
Ensslin HK, Kovar KA, Maurer HH (1996) J Chromatogr B Biomed Sci Appl 683:189–197
Maurer HH, Ensslin HK, Kovar KA (1990) Bull Soc Sci Med Grand-Duche Lux 127(suppl):467–471
Acknowledgments
The authors thank Armin A. Weber and Gabi Ulrich for their support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meyer, M.R., Wilhelm, J., Peters, F.T. et al. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry. Anal Bioanal Chem 397, 1225–1233 (2010). https://doi.org/10.1007/s00216-010-3636-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3636-5